BridgeBio Oncology Therapeutics Inc.
$8.74
-0.44 (-4.79%)
Price as of Aug 28, 2026 market close
Performance
- 1 Month
- +2.8%
- 3 Months
- -2.6%
- YTD
- -30.2%
- 1 Year
- -6.0%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 64.4%
- Largest decline max drawdown, since Aug 2025
- -48.1%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.22
Own BBOT?
See how BBOT contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.